Equity Overview
Price & Market Data
Price: $1.85
Daily Change: +$0.10 / 5.41%
Range: $1.71 - $1.88
Market Cap: $24,611,476
Volume: 44,302
Performance Metrics
1 Week: 11.45%
1 Month: -14.35%
3 Months: -28.85%
6 Months: 25.00%
1 Year: 13.50%
YTD: -32.97%
Company Details
Employees: 6
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.